Menu
Back to User profile » Dr Rupert C Jones
Papers published by Dr Rupert C Jones:
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
Chen W, Sadatsafavi M, Tran TN, Murray RB, Wong CBN, Ali N, Ariti C, Garcia Gil E, Newell A, Alacqua M, Al-Ahmad M, Altraja A, Al-Lehebi R, Bhutani M, Bjermer L, Bjerrum AS, Bourdin A, Bulathsinhala L, von Bülow A, Busby J, Canonica GW, Carter V, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Yoo KH, Heaney LG, Heffler E, Hew M, Hilberg O, Hoyte F, Iwanaga T, Jackson DJ, Jones RC, Koh MS, Kuna P, Larenas-Linnemann D, Lehmann S, Lehtimäki LA, Lyu J, Mahboub B, Maspero J, Menzies-Gow AN, Sirena C, Papadopoulos N, Papaioannou AI, Pérez de Llano L, Perng DW, Peters M, Pfeffer PE, Porsbjerg CM, Popov TA, Rhee CK, Salvi S, Taillé C, Taube C, Torres-Duque CA, Ulrik CS, Ra SW, Wang E, Wechsler ME, Price DB
Journal of Asthma and Allergy 2022, 15:1491-1510
Published Date: 21 October 2022
CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients
Alves L, Pullen R, Hurst JR, Miravitlles M, Carter V, Chen R, Couper A, Dransfield M, Evans A, Hardjojo A, Jones D, Jones R, Kerr M, Kostikas K, Marshall J, Martinez F, Melle MV, Murray R, Muro S, Nordon C, Pollack M, Price C, Sharma A, Singh D, Winders T, Price DB
Patient Related Outcome Measures 2022, 13:53-68
Published Date: 23 February 2022
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care
Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2301-2322
Published Date: 12 August 2021
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients
Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D
Pragmatic and Observational Research 2021, 12:93-104
Published Date: 11 August 2021
Identifying Appropriate Delivery of and Referral to Pulmonary Rehabilitation in Uganda: A Survey Study of People Living with Chronic Respiratory Disease and Health Care Workers
Katagira W, Jones AV, Orme MW, Yusuf ZK, Ndagire P, Nanyonga J, Kasiita R, Kasolo JN, Miah RB, Steiner MC, Jones R, Barton A, Kirenga B, Singh SJ
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2291-2299
Published Date: 10 August 2021
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database [Corrigendum]
Kostikas K, Price D, Gutzwiller FS, Jones B, Loefroth E, Clemens A, Fogel R, Jones R, Cao H
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2559-2560
Published Date: 16 October 2020
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database
Kostikas K, Price D, Gutzwiller FS, Jones B, Loefroth E, Clemens A, Fogel R, Jones R, Cao H
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1729-1738
Published Date: 16 July 2020
Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study
Kostikas K, Rhee CK, Hurst JR, Agostoni P, Cao H, Fogel R, Jones R, Kocks JWH, Mezzi K, Wan Yau Ming S, Ryan R, Price DB
Pragmatic and Observational Research 2020, 11:55-66
Published Date: 2 June 2020
Predicting frequent COPD exacerbations using primary care data [Corrigendum]
Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2471-2472
Published Date: 15 August 2018
Does pulmonary rehabilitation alter patients’ experiences of living with chronic respiratory disease? A qualitative study
Jones R, Muyinda H, Nyakoojo G, Kirenga B, Katagira W, Pooler J
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2375-2385
Published Date: 8 August 2018
Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis
Hurst JR, Dilleen M, Morris K, Hills S, Emir B, Jones R
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:781-792
Published Date: 5 March 2018
A pre–post intervention study of pulmonary rehabilitation for adults with post-tuberculosis lung disease in Uganda
Jones R, Kirenga BJ, Katagira W, Singh SJ, Pooler J, Okwera A, Kasiita R, Enki DG, Creanor S, Barton A
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3533-3539
Published Date: 11 December 2017
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
Jones R, Martin J, Thomas V, Skinner D, Marshall J, Stagno d'Alcontres M, Price D
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2445-2454
Published Date: 17 August 2017
Predicting frequent COPD exacerbations using primary care data
Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2439-2450
Published Date: 9 November 2015
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2207-2217
Published Date: 15 October 2015
Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, King C, Thomas M
Journal of Asthma and Allergy 2015, 8:1-13
Published Date: 14 January 2015